Valuation: Mankind Pharma Limited

Capitalization 1,032B 11.8B 11.45B 10.75B 9.53B 16.9B 18.8B 129B 47.84B 425B 44.25B 43.36B 1,790B P/E ratio 2025 *
52.4x
P/E ratio 2026 * 45.4x
Enterprise value 1,099B 12.57B 12.19B 11.45B 10.15B 18B 20.02B 137B 50.94B 452B 47.12B 46.17B 1,906B EV / Sales 2025 *
8.92x
EV / Sales 2026 * 7.16x
Free-Float
22.83%
Yield 2025 *
0.36%
Yield 2026 * 0.41%
More valuation ratios * Estimated data
Dynamic Chart
1 day-2.15%
1 week-4.18%
Current month+0.53%
1 month-5.69%
3 months-7.50%
6 months+13.76%
Current year-15.00%
More quotes
1 week
2 444.80
Extreme 2444.8
2 559.60
1 month
2 348.05
Extreme 2348.05
2 754.70
Current year
2 348.05
Extreme 2348.05
2 998.40
1 year
1 901.05
Extreme 1901.05
3 054.80
3 years
1 242.00
Extreme 1242
3 054.80
5 years
1 242.00
Extreme 1242
3 054.80
10 years
1 242.00
Extreme 1242
3 054.80
More quotes
Director TitleAgeSince
Chief Executive Officer 49 2007-09-20
Director of Finance/CFO 56 2016-03-02
Compliance Officer 47 2025-01-08
Manager TitleAgeSince
Chairman 69 1991-07-02
Director/Board Member 59 1992-12-21
Director/Board Member 49 2007-09-20
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
-2.15%-4.18%+10.72% - 11.8B
-1.07%+7.21%+17.39%+262.58% 782B
-1.38%+2.62%-26.02%+79.44% 378B
+0.73%+1.56%-1.61%-8.96% 371B
-0.14%+0.11%+9.34%+33.38% 336B
-0.12%+1.72%+29.21%-18.23% 256B
-0.20%+3.92%+20.05%+35.47% 225B
-1.01%-13.42%-31.13%+12.85% 219B
+0.28%+0.88%+9.77%+20.95% 210B
+0.43%+2.05%+1.26%+28.83% 158B
Average -0.45%+0.54%+3.90%+49.59% 294.81B
Weighted average by Cap. -0.51%+2.40%+4.71%+88.01%
See all sector performances

Financials

2025 *2026 *
Net sales 123B 1.41B 1.37B 1.28B 1.14B 2.02B 2.24B 15.37B 5.71B 50.7B 5.28B 5.17B 214B 150B 1.72B 1.67B 1.56B 1.39B 2.46B 2.73B 18.73B 6.96B 61.8B 6.44B 6.31B 260B
Net income 19.6B 224M 217M 204M 181M 321M 357M 2.45B 908M 8.07B 840M 823M 33.99B 22.71B 260M 252M 236M 210M 372M 413M 2.83B 1.05B 9.35B 973M 954M 39.38B
Net Debt 66.94B 765M 742M 697M 618M 1.1B 1.22B 8.35B 3.1B 27.55B 2.87B 2.81B 116B 42.61B 487M 473M 444M 393M 698M 776M 5.32B 1.97B 17.54B 1.83B 1.79B 73.9B
More financial data * Estimated data
Logo Mankind Pharma Limited
Mankind Pharma Limited is an India-based pharmaceutical company. It is engaged in developing, manufacturing, and marketing a range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It offers healthcare solutions for a range of healthcare needs with a portfolio that includes anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/ central nervous system, vitamins, minerals and nutrients and respiratory therapies. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others. Its branded product portfolio spans women’s health, fertility and critical care, with several brands in their respective therapy areas. Its subsidiaries include Lifestar Pharma Private Limited, Magnet Labs Private Limited, Jaspack Industries Private Limited, and others.
Employees
19,540
Calendar
More about the company
Date Price Change Volume
25-02-11 2,448.00 -2.16% 679,998
25-02-10 2,502.05 -0.66% 421,865
25-02-07 2,518.60 +1.55% 630,850
25-02-06 2,480.10 -0.12% 473,065
25-02-05 2,483.00 -2.82% 331,196

Delayed Quote NSE India S.E., February 11, 2025 at 02:57 am EST

More quotes
Trading Rating
Investor Rating
ESG MSCI
BB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
2,502.05INR
Average target price
2,822.81INR
Spread / Average Target
+12.82%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. MANKIND Stock